Stock Price

TaseIcon BVXV.TA (Ag)

+12.84% 49.20

NasdaqIcon32x32 BVXV (US$)

+0.38% 5.25

One US ADS = 40 Tel Aviv shares

IR Kit

Fact Sheet

Presentation

IR Contact

Kenny Green
GK Investor Relations

+1 646 201 9246

Company Profile

BiondVax is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. BiondVax’s technology utilizes a unique, proprietary combination of conserved and common peptides from influenza virus proteins to activate both arms of the immune system for a cross-protecting and long-lasting effect.

Recent News